News/announcements

 

New product launched: BIOQUELL Z - Zone/room/building bio-decontamination

BIOQUELL has launched the BIOQUELL Z, a radically new concept in safe and effective micro organism deactivation.

Read more

Profile: Whats Bugging Nick Adams, The Telegraph, Friday 29th December 2006

Bioquell CEO Nick Adams tells of the frustrations and obstacles faced in the UK healthcare sector in the ongoing battle against hospital superbugs.

Read more

Proposed establishment of a Special Option-based incentive scheme

BIOQUELL PLC, announces that it is seeking shareholders’ approval for the establishment of a Special Option-based incentive scheme for the Group’s senior management.

Read more

Technical note for machine tools

A new technical note has been added to the site relating to machine tools.

Read more

Big fines for non-compliance

The Federal Communications Commission (FCC) has proposed a $1 million forfeiture against Behringer USA, Inc. for apparent violation of the FCC’s equipment authorization rules 

Read more

Results of a “superbug” eradication trial in a US hospital

BIOQUELL PLC, the UK leader in specialist bio-decontamination technology and testing/compliance services, announces further data relating to a “superbug” eradication trial in a US hospital. 

Read more

Dalek exterminates ward bugs, The Times article

Machine that kills hospital infections is being ignored by the NHS, reports Nigel Hawkes.

Read more

Preliminary results of a “superbug” eradication trial in a US hospital

BIOQUELL PLC announces a successful “superbug” eradication trial and an update on the clinical trials of its new wound healing technology.
 

Read more

Cape announces the acquisition of TRL and KTL

Cape Engineering UK Limited (“Cape”) has announced today that it has acquired the business and fixed assets of two UKAS accredited test laboratories: TRL Compliance Services Limited (“TRL”) and Laboratory Accreditation Services Limited (which trades as “KTL”).

Read more